Market Size of Europe Self-monitoring Blood Glucose Devices Industry
| Study Period | 2018 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 3.14 Billion |
| Market Size (2029) | USD 4.29 Billion |
| CAGR (2024 - 2029) | 6.38 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Europe Self-monitoring Blood Glucose Device Market Analysis
The Europe Self-monitoring Blood Glucose Devices Market size is estimated at USD 3.14 billion in 2024, and is expected to reach USD 4.29 billion by 2029, growing at a CAGR of 6.38% during the forecast period (2024-2029).
European countries are suffering from the burden of high diabetes expenditure due to its rising prevalence. Technological advancements have increased over the period in Diabetes care devices for safer and more accurate measurement of blood glucose levels.
According to the IDF report, about 1 in 11 adults in Europe had diabetes, which accounted for approximately 61 million. These figures indicated that approximately 19.6% of global expenditures were spent on diabetes in Europe. Every year, 21,600 children are added to the type-1 diabetic population pool. The European region has witnessed an alarming increase in the prevalence of diabetes in recent years. Patients with diabetes require many corrections throughout the day for maintaining nominal blood glucose levels, such as oral anti-diabetic medication or the ingestion of additional carbohydrates, by monitoring their blood glucose levels.
According to the German Diabetes Center (DDZ), about 8.5 million people in Germany are affected by diabetes. The number of people with type-2 diabetes in Germany will continue to increase over the next twenty years. Researchers at DDZ estimate that up to 12 million people might suffer from metabolic disorders in 2040.
Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period.
Europe Self-monitoring Blood Glucose Device Industry Segmentation
Self-monitoring of blood glucose is an approach used by diabetic patients to measure their blood sugar level using a glucometer, test strips, and lancets. Based on the readings, patients can adjust or check the effect of their treatment. The European self-monitoring blood glucose device market is segmented into components and geography . The report offers the value (in USD) and volume (in units) for the above segments.
| Component | |
| Glucometer Devices | |
| Test Strips | |
| Lancets |
| Geography | |
| France | |
| Germany | |
| Italy | |
| Rest of Europe | |
| Russia | |
| Spain | |
| United Kingdom |
Europe Self-monitoring Blood Glucose Devices Market Size Summary
The European self-monitoring blood glucose devices market is poised for significant growth, driven by the increasing prevalence of diabetes and the rising demand for effective diabetes management solutions. Technological advancements in diabetes care devices have enhanced the accuracy and safety of blood glucose measurements, addressing the growing healthcare burden in the region. The market is characterized by the integration of innovative technologies, such as digital health apps and automated insulin titration software, which support self-management and improve patient outcomes. These developments are further supported by government initiatives and collaborations within the healthcare industry, aiming to standardize and improve diabetes care services across Europe.
Germany is expected to lead the market, benefiting from its robust social health insurance system and a high adoption rate of self-monitoring devices. The market is fragmented, with major global manufacturers like Abbott, LifeScan, and Roche holding significant shares, while local players cater to region-specific needs. Innovations in device components, such as the Accu-Chek FastClix, are enhancing user convenience and encouraging adoption. Recent studies and product launches, such as Roche's point-of-care blood glucose monitor, underscore the ongoing advancements and commitment to improving diabetes management solutions in Europe. These factors collectively contribute to the anticipated growth of the market over the forecast period.
Europe Self-monitoring Blood Glucose Devices Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.3 Market Restraints
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Bargaining Power of Suppliers
-
1.4.2 Bargaining Power of Consumers
-
1.4.3 Threat of New Entrants
-
1.4.4 Threat of Substitute Products and Services
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 Component
-
2.1.1 Glucometer Devices
-
2.1.2 Test Strips
-
2.1.3 Lancets
-
-
2.2 Geography
-
2.2.1 France
-
2.2.2 Germany
-
2.2.3 Italy
-
2.2.4 Rest of Europe
-
2.2.5 Russia
-
2.2.6 Spain
-
2.2.7 United Kingdom
-
-
Europe Self-monitoring Blood Glucose Devices Market Size FAQs
How big is the Europe Self-monitoring Blood Glucose Devices Market?
The Europe Self-monitoring Blood Glucose Devices Market size is expected to reach USD 3.14 billion in 2024 and grow at a CAGR of 6.38% to reach USD 4.29 billion by 2029.
What is the current Europe Self-monitoring Blood Glucose Devices Market size?
In 2024, the Europe Self-monitoring Blood Glucose Devices Market size is expected to reach USD 3.14 billion.
